VAERS Explorer
Back to explore

Report #2897204

Received May 20, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
1.2 yrs
State
VA
Recovered
Unknown
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
PNC15PNEUMO (VAXNEUVANCE)MERCK & CO. INC.1
PPVPNEUMO (NO BRAND NAME)UNKNOWN MANUFACTURER1
PPVPNEUMO (NO BRAND NAME)UNKNOWN MANUFACTURER2

Symptoms (3)

Pneumonia pneumococcalStreptococcus test positiveVaccination failure

Symptom narrative

patient with a serotype 3 infection had received 2 PCV13 doses and 1 dose of PCV15 / infections caused by this serotype despite vaccination; Literature Report. This Literature marketed report has been received from the authors of a published article, titled as stated above referred to a 20-months-old patient of unknown gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. The patient's concurrent conditions included hospitalization. On an unknown date (also reported as "at about 14 months old"), the patient started therapy with 15-Valent Pneumococcal Conjugate Vaccine (CRM197) (Manufacturer Unknown), first dose, (Strength, dose, vaccination scheme, anatomical route of vaccination, lot Number, and expiration date were not reported), as prophylaxis. On an unknown date (also reported as "at about 14 months old"), the patient started therapy with Pneumococcal 13 valent vaccine, first dose, (Strength, dose, vaccination scheme, anatomical route of vaccination, lot Number, and expiration date were not reported), as prophylaxis. On an unknown date (also reported as "at about 14 months old"), the patient started therapy with Pneumococcal 13 valent vaccine, second dose, (Strength, dose, vaccination scheme, anatomical route of vaccination, lot Number, and expiration date were not reported), as prophylaxis. On an unknown date, the patient experienced Pneumococcal isolate serotype 3 infection despite vaccination (Vaccination failure). At the time of reporting, the Outcome of Vaccination failure was not provided. Lot # is being requested and will be submitted if received. A copy of the published article is attached as further documentation of the patient/s experience.

Current illness

Hospitalization

Lab data

Test Name: Pneumococcal serotype; Result Unstructured Data: Serotype 3 infection